Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
Jumanne, 14 Julai 2026, 12:55:47 UTC
Hepatic encephalopathy (HE)
Hepatic encephalopathy (HE)
Hepatic encephalopathy (HE) is defined as “a condition which reflects a spectrum of neuropsychiatric abnormalities seen in patients with liver dysfunction after exclusion of other known brain disease.”
Clinical presentation
Stage I
Mild confusion
Agitation
Irritability
Sleep disturbance
Decreased attention
Stage II
Lethargy
Disorientation
Inappropriate behavior
Drowsiness
Stage III
Somnolent but arousable
Slurred speech
Confused
Aggressive behavior
Stage IV
Coma
Pharmacological treatment
L-Ornithine L-Aspartate (IV) 10 g 8 hourly daily for 3–5 days
THEN
L-Ornithine L-Aspartate (PO) 9 g 24 hourly in divided doses for 4–12 weeks
AND
Lactulose solution (PO) for bowel cleansing when required
Episode of hepatic encephalopathy (grade 2 or higher) — enemas
0.9% sodium chloride 300 mL in 1000 mL water 2 hourly until there is clinical improvement
Episode of hepatic encephalopathy (able to tolerate oral administration)
Lactulose (PO): 45 mL every hour until there is bowel movement and clinical improvement
Outpatient therapy
Lactulose (PO): 15–45 mL 8–12 hourly until there are 2–3 bowel movements per day
Additional pharmacological treatment
Metronidazole (PO) 400 mg 8 hourly for 7 days
AND
Ceftriaxone (IV) 1 g 12 hourly for 7 days (if evidence of spontaneous bacterial peritonitis)
Precipitants of hepatic encephalopathy
Metabolic and electrolyte causes
Hyponatremia
Hypokalemia
Alkalosis
Azotemia
Dehydration
Gastrointestinal causes
Gastrointestinal bleeding
Diarrhea
Vomiting
Constipation
Excessive paracentesis
Infectious causes
Infection
Drug-related causes
Sedative drugs (narcotics, sleep aids, antihistaminics)
Diuretics
Other causes
Surgery
Fluid restriction
Excessive protein intake
Imeandikwa:
Jumanne, 23 Juni 2026, 3:20:52 UTC
References:
